Form 4: BridgeBio Pharma Executive Sells Shares to Cover Tax Obligations

BridgeBio Pharma's President and COO, Thomas Trimarchi, sold 17,936 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Thomas Trimarchi, President and COO of BridgeBio Pharma, sold 17,936 shares of common stock on November 16, 2024.
• The sale was executed at a price of $23.72 per share.
• This transaction was to cover tax obligations arising from the vesting of 32,432 restricted stock units.
• Following the transaction, Mr. Trimarchi directly owns 377,987 shares of BridgeBio Pharma common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives to cover tax obligations related to stock-based compensation. It is common for executives to sell shares after vesting to cover taxes.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across the industry.
• Many companies use restricted stock units as part of their compensation packages, leading to similar tax-related sales by executives.
• The number of shares sold and the price are within the typical range for such transactions.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

BridgeBio Pharma, BBIO, insider trading, stock sale, executive, Thomas Trimarchi, restricted stock units, tax obligations